Pricing viral hepatitis as part of universal health coverage

In the past decade, the profile of viral hepatitis has increased on the global health agenda with a greater recognition of the burden of disease, availability of highly effective vaccines (for hepatitis A and B), highly effective treatments (for hepatitis B and C), and greater political efforts to support hepatitis work globally.1Stanaway JD Flaxman AD Naghavi M et al.The global burden of viral hepatitis from 1990 to 2013: findings from the...